Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (302)	7/31/2000 10:40:29 PM
From: reno21	Read Replies (2) \| Respond to of 557

TGEN has problems because of the boy that died in clinical trials. I know that it wasn't a TGEN drug but it still hurts. I hold (long!!!!) AVN, NBSC and TTP. Any comments or serious recommendations? What are the darlings of this bulletin board? NBSC's float can be purchased for $18 million and they have a BIG patent for proteome research. There is a bulletin board here at Silicon Investor, but it is closed to new investors. Here is the URL: dgibt.com